VALSECCHI, CARLA
VALSECCHI, CARLA
Universita' degli Studi di MILANO
Anti-emicizumab antibodies do not cross-react with mim8 in vitro
2023 C. Valsecchi, R. Gualtierotti, S. Arcudi, A. Ciavarella, S.M. Siboni, L. Schiavone, M. Beeg, M. Gobbi, F. Peyvandi
Performance of a clinical risk prediction model for inhibitor formation in severe haemophilia A
2021 S. Hassan, R. Palla, C. Valsecchi, I. Garagiola, A. El-Beshlawy, M. Elalfy, V. Ramanan, P. Eshghi, M. Karimi, S.C. Gouw, P.M. Mannucci, F.R. Rosendaal, F. Peyvandi
Anti-TNF-α treatment reduces the baseline procoagulant imbalance of patients with inflammatory bowel diseases
2021 A. Tripodi, L. Spina, L.F. Pisani, L. Padovan, F. Cavallaro, V. Chantarangkul, C. Valsecchi, F. Peyvandi, M. Vecchi
Characterization of the neutralizing anti-emicizumab antibody in a patient with haemophilia A and inhibitor
2021 C. Valsecchi, M. Gobbi, M. Beeg, T. Adams, G. Castaman, L. Schiavone, J.A. Huntington, F. Peyvandi
IgG subclasses as biomarkers for persistence of factor VIII inhibitors in previously untreated patients with severe haemophilia A
2020 F. Peyvandi, S. Miri, P. Bucciarelli, C. Valsecchi, L. Schiavone, M. Boscarino, R. Palla, P.M. Mannucci, F.R. Rosendaal
Molecular Aggregation of Marketed Recombinant FVIII Products: Biochemical Evidence and Functional Effects
2019 R. De Cristofaro, M. Sacco, S. Lancellotti, F. Berruti, I. Garagiola, C. Valsecchi, M. Basso, E. Di Stasio, F. Peyvandi
Clinical and Laboratory Features of Patients with Acquired Thrombotic Thrombocytopenic Purpura: Fourteen Years of the Milan TTP Registry
2019 I. Mancini, S. Pontiggia, R. Palla, A. Artoni, C. Valsecchi, B. Ferrari, D. Mikovic, F. Payvandi
Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A
2017 A. Cannavò, C. Valsecchi, I. Garagiola, R. Palla, P.M. Mannucci, F.R. Rosendaal, F. Peyvandi
ADAMTS13-specific circulating immune complexes as potential predictors of relapse in patients with acquired thrombotic thrombocytopenic purpura
2017 I. Mancini, B. Ferrari, C. Valsecchi, S. Pontiggia, M. Fornili, E. Biganzoli, F. Peyvandi
Next-generation sequencing and in vitro expression study of ADAMTS13 single nucleotide variants in deep vein thrombosis
2016 M.T. Pagliari, L.A. Lotta, H.G. De Haan, C. Valsecchi, G. Casoli, S. Pontiggia, I. Martinelli, S.M. Passamonti, F.R. Rosendaal, F. Peyvandi
FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients
2014 I. Mancini, C. Valsecchi, L.A. Lotta, L. Deforche, S. Pontiggia, M. Bajetta, R. Palla, K. Vanhoorelbeke, F. Peyvandi
Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpura
2014 L.A. Lotta, C. Valsecchi, S. Pontiggia, I. Mancini, A. Cannavò, A. Artoni, D. Mikovic, G. Meloni, F. Peyvandi
Next-generation sequencing study finds an excess of rare, coding single-nucleotide variants of ADAMTS13 in patients with deep vein thrombosis
2013 L.A. Lotta, G. Tuana, J. Yu, I. Martinelli, M. Wang, F. Yu, S.M. Passamonti, E. Pappalardo, C. Valsecchi, S.E. Scherer, W. Hale, D.M. Muzny, G. Randi, F.R. Rosendaal, R.A. Gibbs, F. Peyvandi
ADAMTS13 content in plasma-derived factor VIII/von Willebrand factor concentrates
2013 F. Peyvandi, P.M. Mannucci, C. Valsecchi, S. Pontiggia, C. Farina, A.D. Retzios
Measurement of anti-ADAMTS13 neutralising autoantibodies: a comparison between CBA and FRET assays
2012 I. Mancini, C. Valsecchi, R. Palla, L.A. Lotta, F. Peyvandi
ADAMTS13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura
2012 G. Bettoni, R. Palla, C. Valsecchi, D. Consonni, L.A. Lotta, S.M. Trisolini, I. Mancini, K.M. Musallam, F.R. Rosendaal, F. Peyvandi
Comparison of assays to evaluate ADAMTS13 activity in patients’ plasma
2008 R. Palla, M. Spreafico, C. Valsecchi, L. Beretta, P.M. Mannucci, F. Peyvandi
Nonsense-mediated mRNA decay in the ADAMTS13 gene caused by a 29-nucleotide deletion
2008 I. Garagiola, C. Valsecchi, S. Lavoretano, H. Oren, M. Bohm, F. Peyvandi
Evaluation of assays to measure ADAMTS13 activity in patients' plasma
2008 R. Palla, M. Spreafico, C. Valsecchi, P.M. Mannucci, F. Peyvandi
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission
2008 F. Peyvandi, S. Lavoretano, R. Palla, H.B. Feys, K. Vanhoorelbeke, T. Battaglioli, C. Valsecchi, M.T. Canciani, F. Fabris, S. Zver, M. Réti, D. Mikovic, M. Karimi, G. Giuffrida, L. Laurenti, P.M. Mannucci